CytomX Therapeutics (CTMX) Prepaid Assets (2014 - 2026)

CytomX Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• Quarterly Prepaid Assets rose 20.0% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (up 20.0% YoY) and the FY2025 annual result came in at $4.9 million, up 35.68% from the prior year.
• Prepaid Assets was $5.7 million for Q1 2026 at CytomX Therapeutics, up from $4.9 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $7.5 million in Q4 2022 and bottomed at $3.1 million in Q2 2024.
• A 5-year average of $4.7 million and a median of $4.7 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 74.24% — and 2024, when it tumbled 43.37%.
• CytomX Therapeutics' Prepaid Assets stood at $7.5 million in 2022, then sank by 33.1% to $5.0 million in 2023, then fell by 28.35% to $3.6 million in 2024, then soared by 35.68% to $4.9 million in 2025, then grew by 18.27% to $5.7 million in 2026.
• Business Quant data shows CTMX's Prepaid Assets at $5.7 million in Q1 2026, $4.9 million in Q4 2025, and $4.0 million in Q3 2025.